Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO study

BACKGROUND: Immunotherapy demonstrated remarkable efficacy in metastatic colorectal cancers (mCRCs) with mismatch repair deficiency (MMRd)/microsatellite instability (MSI). However, data regarding efficacy and safety of immunotherapy in the routine clinical practice are scarce. PATIENTS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Alouani, E., Mercier, M., Flecchia, C., Auclin, E., Hollebecque, A., Mazard, T., Turpin, A., Pernot, S., Cohen, R., Dutherage, M., Kim, S., Sclafani, F., Ben-Abdelghani, M., Herve, C., Aparicio, T., De La Fouchardière, C., Perkins, G., Hautefeuille, V., Jaffrelot, M., Gallois, C., Bongard, V., Tougeron, D., Taïeb, J., Guimbaud, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265605/
https://www.ncbi.nlm.nih.gov/pubmed/37244250
http://dx.doi.org/10.1016/j.esmoop.2023.101574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265605/
https://www.ncbi.nlm.nih.gov/pubmed/37244250
http://dx.doi.org/10.1016/j.esmoop.2023.101574

Ejemplares similares